Mondelez International Inc's first-quarter revenue surged to $7.24 billion from $6.71 billion a year ago, beating Wall Street analysts’ average estimate of $7.02 billion, according to IBES data from Refinitiv.
The increase in revenue was attributed to the higher demand for its biscuits and chocolates in Asia and Europe.
Sales of food and snacks soared during the pandemic as consumers sought comfort in familiar brands.
Mondelez's net revenue from the North American market rose 4.3 percent to $1.98 billion, while its revenue from Europe grew 10.2 percent to $2.85 billion.
Quarterly net earnings attributable to the company soared to $961 million, or 68 cents per share from $736 million, or 51 cents per share, last year.


Gold Prices Slide Below $5,000 as Strong Dollar and Central Bank Outlook Weigh on Metals
Fed Governor Lisa Cook Warns Inflation Risks Remain as Rates Stay Steady
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
U.S.-India Trade Framework Signals Major Shift in Tariffs, Energy, and Supply Chains
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
South Korea’s Weak Won Struggles as Retail Investors Pour Money Into U.S. Stocks
Trump Signs Executive Order Threatening 25% Tariffs on Countries Trading With Iran
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
Japan Economy Poised for Q4 2025 Growth as Investment and Consumption Hold Firm
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment
Ford and Geely Explore Strategic Manufacturing Partnership in Europe
India–U.S. Interim Trade Pact Cuts Auto Tariffs but Leaves Tesla Out
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning 



